Evidence map›Paper›PMID 31709779›Full record

SynthesisArthritis care & research2019

2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity Measures.

Bryant R England, Benedict K Tiong, Martin J Bergman, Jeffrey R Curtis, Salahuddin Kazi, Ted R Mikuls, James R O'Dell, Veena K Ranganath, Alex Limanni, Lisa G Suter and 1 more

Abstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Arthritis care & research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 151 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
151citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

151 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Guideline
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

91 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Bryant R EnglandVA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha.ORCID 0000-0002-9649-3588
Benedict K TiongUniversity of California, Los Angeles.
Martin J BergmanDrexel University, Philadelphia, Pennsylvania.
Jeffrey R CurtisUniversity of Alabama at Birmingham.ORCID 0000-0002-8907-8976
Salahuddin KaziUniversity of Texas Southwestern, Dallas.
Ted R MikulsVA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha.ORCID 0000-0002-0897-2272
James R O'DellVA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha.
Veena K RanganathUniversity of California, Los Angeles.
Alex LimanniArthritis Centers of Texas, Dallas.
Lisa G SuterYale University, New Haven, Connecticut, and VA Medical Center, West Haven, Connecticut.
Kaleb MichaudUniversity of Nebraska Medical Center, Omaha, and FORWARD, the National Databank for Rheumatic Diseases, Wichita, Kansas.ORCID 0000-0002-5350-3934

Funding

Tracking and Evaluation CoreU54GM115458 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI HOLSTEIN, SARAH A · 2016 to 2025
$42.8M
UAB Multidisciplinary Clinical Research CenterP60AR064172 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BRIDGES, S LOUIS · 2013 to 2018
$4.5M
American College of RheumatologyDartmouth InstituteNIAMS NIH HHS P60 AR064172NIGMS NIH HHS U54 GM115458Patient-Centered Outcomes Research InstituteRheumatology Research FoundationUniversity of Nebraska Medical CenterVAYale New Haven Health System
6 · The paper itself

Abstract

objectiveTo provide updated American College of Rheumatology (ACR) recommendations on rheumatoid arthritis (RA) disease activity measurements to facilitate a treat-to-target approach in routine clinical care.

methodsA working group conducted a systematic literature review from the time of the prior ACR recommendations literature search. Properties of disease activity measures were abstracted, and study quality was assessed using the Consensus-Based Standards for the selection of Health Measurement Instruments 4-point scoring method, allowing for overall level of evidence assessment. Measures that fulfilled a minimum standard were identified, and through a modified Delphi process preferred measures were selected for regular use in most clinic settings.

resultsThe search identified 5,199 articles, of which 110 were included in the review. This search identified 46 RA disease activity measures that contained patient, provider, laboratory, and/or imaging data. Descriptions of the measures, properties, study quality, level of evidence, and feasibility were abstracted and scored. Following a modified Delphi process, 11 measures fulfilled a minimum standard for regular use in most clinic settings, and 5 measures were recommended: the Disease Activity Score in 28 Joints with Erythrocyte Sedimentation Rate or C-Reactive Protein Level, Clinical Disease Activity Index, Simplified Disease Activity Index, Routine Assessment of Patient Index Data 3, and Patient Activity Scale-II.

conclusionWe have updated prior ACR recommendations for preferred RA disease activity measures, identifying 11 measures that met a minimum standard for regular use and 5 measures that were preferred for regular use in most clinic settings.

Indexed as

Practice Guidelines as TopicSocieties, MedicalArthritis, RheumatoidDisease ProgressionHumansRheumatologySeverity of Illness IndexUnited States

Identifiers

PMID31709779
PMCPMC6884664

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.